https://www.selleckchem.com/pr....oducts/telacebec-q20
descending sudden hearing loss and high frequency descending hearing loss. Bladder cancer (BC) is one of the most common malignancies worldwide. Several biomarkers related to the prognosis of patients with BC have previously been identified. However, these prognostic models use only one gene and are thus not reliable or accurate enough. The purpose of our study was to develop an innovative gene signature that has greater prognostic value in BC. So, in this study, we performed mRNA expression profiling of glycolysis-related genes
Curtir
Comentario
Compartilhar
